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Abstract: We report on screening tests of 66 extracts obtained from 35 marine sponge 
species from the Caribbean Sea (Curaç ao) and from eight species from the Great Barrier 
Reef (Lizard Island). Extracts were prepared in aqueous and organic solvents and were 
tested for hemolytic, hemagglutinating, antibacterial and anti-acetylcholinesterase (AChE) 
activities, as well as their ability to inhibit or activate cell protein phosphatase 1 (PP1). The 
most  interesting  activities  were  obtained  from  extracts  of  Ircinia  felix,  Pandaros 
acanthifolium, Topsentia ophiraphidites, Verongula rigida and Neofibularia nolitangere. 
Aqueous and organic extracts of I. felix and V. rigida showed strong antibacterial activity. 
Topsentia aqueous and some organic extracts were strongly hemolytic, as were all organic 
extracts from I. felix. The strongest hemolytic activity was observed in aqueous extracts 
from P. acanthifolium. Organic extracts of N. nolitangere and I. felix inhibited PP1. The 
aqueous  extract  from  Myrmekioderma  styx  possessed  the  strongest  hemagglutinating 
activity,  whilst  AChE  inhibiting  activity  was  found  only  in  a  few  sponges  and  was 
generally weak, except in the methanolic extract of T. ophiraphidites. 
Keywords: tropical marine sponges; hemolysis; hemagglutination; antibacterial activity; 
acetylcholinesterase (AChE) inhibition; protein phosphatase 1 (PP1) inhibition/activation 
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1. Introduction 
Marine sponges (Porifera) are primitive metazoans. Sponge species are predominantly marine and 
sessile. They produce a plethora of compounds that protect them from predators and/or possibility 
from being infected and fouled by other marine organisms [1]. Marine sponges are considered to be 
true “chemical factories” producing hundreds of unique chemical compounds, many of which have 
been isolated and their structure determined, but their biological roles and activities are still largely 
unknown [2].  
Despite the popular and somewhat overexploited statement that marine sponges are an important 
source of new bioactive compounds that may be used in various biomedical applications, so far only a 
few have found such an application [3]. Nevertheless, a large number of sponge secondary metabolites 
show  interesting  biological  activities,  for  example  calyculins  from  Discodermia  calyx)  [4], 
discodermolide  from  D.  dissoluta  [5],  latrunculins  from  Latrunculia  magnifica  [6–9],  and 
spongistatins  from  Spongia  sp.  and  Spirastrella  sp.  [10–12].  They  are  cytotoxic,  inhibit  cell 
proliferation and could be used as chemotherapeutics. These compounds differ structurally and act on 
different cytoskeletal elements, but have similar antiprolific and antitumoral activities.  
Remarkable progress has been made with halichondrin B initially found in the Japanese marine 
sponge Halichondria okadai [13]; later, similar compounds were also found in other sponges such as 
Phakelia carteri [14] and Lissodendoryx sp. [15]. Halichondrin B, as a potential chemotherapeutic 
agent, has advanced to preclinical studies, however, due to the limited supply of the natural compound, 
a  derivative  of  halichondrin  B,  E7389,  was  synthesized  which  proved  to  be  a  significantly  more 
effective antitumor agent in animal models. As a result, E7389 was approved for clinical trials in 2001. 
Early results from a Phase II trial reported in December 2005 indicated that 15 percent of breast cancer 
patients  in  that  trial,  whose cancer was resistant to other treatments, responded to treatment with 
E7389.  The  National  Cancer  Institute  is  planning  several  Phase  II  clinical  trials  to  test  the 
effectiveness of E7389 in treating a variety of tumors including ovarian, prostate, bladder, pancreatic 
head  and  neck  cancers  [16].  Other  examples  of  pharmaceuticals  based  on  marine  sponge  natural 
products  are  Ara-A and  Ara-C  obtained from  Cryptotethya  cripta both  of which  are  marketed  as 
antiviral and anticancer drugs [3]. 
Despite the fact that cytotoxicity is the most widespread characteristic of compounds isolated from 
marine  sponges,  they  also  possess  other  activities.  Due  to  the  sessile  nature  of  sponges  it  is  not 
surprising that many of their natural products show strong antifouling activities. Several reviews on 
such compounds have been published recently [17,18]. 
So far only a few sponge metabolites have been reported to act as receptor/channel modulators or 
enzyme inhibitors, these include compounds from Penares sp. such as azetadins which inhibit protein 
kinase  C [19,20]  and penaramides  that  bind  to  the N-type calcium channels  thus competing with  
ω-conotoxin  binding  sites  [21],  cyclostellettamines  from  Stelletta  maxima,  alkylpyridinium  cyclic 
dimers that bind to muscarinic receptors of type M1, M2 and M3 [22], linear peptides from Theonella 
swinhoei,  that  act  as  inhibitors  of  thrombin  [23]  and  serine  proteases  [24],  and  alkypyridinium 
polymers,  isolated  from  Reniera  sarai,  which  strongly  inhibit  AChE  and  may  act  as  anticancer 
compounds affecting cholinergic system expressed in a variety of cancer cell lines [25–27]. A large Mar. Drugs 2010, 8                       
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number of secondary metabolites from a variety of marine sponges were reported to possess antiviral, 
antifungal and antibacterial activities, among them many bromotyrosine derivates [2].  
In the present study we report the screening results of several biological activities found in aqueous 
and organic extracts from 43 tropical marine sponge species that could possibly lead to the discovery 
of novel compounds of pharmacological interest. 
2. Results and Discussion 
The  majority  of  Caribbean  and  Australian  tropical  marine  sponge  extracts  tested  in  this  study 
possessed at least one biological activity (Suppl. Table 1a and 1b). However, a substantial amount of 
material was used in these preliminary assays, and therefore dilutions of the active samples were also 
tested. A small number of sponge extracts exhibited selective toxicity. After dilution of these extracts 
their selective toxicity became more evident. On the other hand many extracts exhibited broad toxicity 
which was almost completely lost after dilution. Broad toxicity could be attributed to the large number 
and high concentration of different compounds in the undiluted extracts. In the case of crude samples, 
we cannot overlook the fact that these compounds may act synergistically resulting in broad toxicity. 
Due  to  the  different  amounts  of  different  compounds  in  the  tested  samples  the  level  of  certain 
compounds after dilution became to low to be effective, and only those whose concentrations were still 
high enough prevailed. As an example, undiluted organic extracts from Agelas clathrodes (#81) were 
strongly  hemolytic and showed substantial AChE inhibitory activity. After dilution both activities 
were almost completly lost (Tables 1 and 3). Extracts from Ircinia felix (#59), on the other hand 
showed strong hemolytic and considerable AChE inhibitory activity. After dilution the former activity 
was completely preserved while the later was completely lost. Undiluted organic extracts from the 
same sponge also showed moderate PP1 inhibition, while heated aqueous extracts exhibited modest 
activation of the same enzyme. After dilution the former activity was lost while the later remained 
unchanged (Tables 1 and 4).  
Hemolytic activity was present in only  a few aqueous samples, whereas the same activity was 
observed  in  nearly  half  of  the  organic  extracts.  Acetone  extracts  possessed  the  highest  levels  of 
hemolytic activity, followed by butanol and methanol extracts; the latter contained the highest amount 
of extracted material. Aqueous extracts whose hemolytic activity was lost after heating were of special 
interest as this indicated the presence of a proteinaceous active compound(s). Based on these criteria 
such hemolytic proteins may be present in Pandaros acanthifolium (#76), however a second specimen 
from a different location (#14) did not exhibit any hemolytic activity. The unheated aqueous extract 
from  Spheciospongia  vesparium  (#69)  was  hemolytic,  but  again  another  specimen  (#45)  from  a 
different location was not. These results indicate that the same species from a different location may 
harbor different chemistry possibly originating from endosymbiotic organisms present in the particular 
collected specimen. Such observations were quite common in this study. Another interesting species 
that showed strong hemolytic activity was Topsentia ophiraphidites (#99). In this case, the active 
compound responsible for hemolytic activity was ascribed to be non-proteinaceous in nature, as its 
activity was retained after heating. Hemolytic assays using diluted samples of aqueous sponge extracts 
confirmed that P. acanthifolium, S. vesparium and T. ophiraphidites contained the highest levels of 
hemolytic activity. The most active organic extracts after dilution were those from Agelas clathrodes Mar. Drugs 2010, 8                       
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(#81),  Ircinia  felix  (#59)  and  Lissodendoryx  colombiensis  (#110).  All  three  extracts  from  I.  felix 
possessed considerable hemolytic activity. Of the two other Ircinia species only one organic extract 
was active (Table 1). Hemolytic proteins isolated from marine sponges are rare. Two such examples 
are suberitin, isolated from the Mediterranean sponge Suberites domuncula [30] and a hemolysin from 
Tethya lincurum [31]. To date no hemolytic compounds have been reported from the marine sponges 
used in this study. An aqueous extract from S. vesparium was previously reported to exhibit low 
toxicity in mice, however this toxicity was not attributed to hemolytic activity [32].  
Moderate hemagglutinating activity has been detected in 14 aqueous sponge extracts, one showed 
activity in the heated fraction only and extracts from two sponge species, both heated and unheated 
fractions, were active. After dilution only one extract from Myrmekioderma styx (#86) showed strong 
hemagglutinating activity (7.2 μg/mL). The heated fraction lost its activity, suggesting the compound 
responsible for hemagglutinating activity is probably a lectin or a protein. So far, several compounds 
with  antimicrobial  and  cytotoxic  activities  have  been  isolated  from  this  species  [33–36],  but  no 
hemagglutinating activity has been reported.  
A  large  number  of  compounds  exhibiting  antimicrobial  activity  with  potential  biomedical 
application have been isolated from marine sponges [39]. Therefore, the fact that the majority of the 
sponges investigated in this study possess antimicrobial activity is not surprising (Suppl. Tables 1a  
and 1b). Almost all samples (only two samples showed no activity) were able to prevent growth of at 
least one bacterial strain. Many of the samples inhibited the growth of Gram positive bacteria, but only 
few affected the growth of Gram negative bacteria. Organic extracts tended to be more active than the 
aqueous extracts. Diluted samples of those sponges that showed the highest antibacterial activity were 
retested and results expressed as a minimal inhibitory concentration (MIC, Table 2). The strongest 
antimicrobial activity was found in the organic extracts from the sponges of the genus Ircinia and 
Verongula. All extracts from I. felix (#59, #93) showed considerable antimicrobial activity. The most 
active samples were the butanol extracts from I. strobilina (MIC = 30 ng/mL), the acetone extract from 
V. gigantea (#44, MIC = 50 ng/mL) and the butanol extract from V. rigida (#38, MIC = 80 ng/mL). 
The highest antimicrobial activity in the aqueous extracts was found in the unheated extract from I. 
felix (#59). Sponges from the genus Ircinia are among the most widely studied in terms of their natural 
products. A number of different compounds have been isolated and characterized, many of them being 
antimicrobial [37, 38]. The only extracts that showed considerable activity towards Gram negative 
strain were those from Topsentia ophiraphidites (#99) and Aplysina archeri (#61). The antimicrobial 
activity of the unheated aqueous extract (MIC = 48 µ g/mL) was about 100 fold more potent than the 
heated extracts, again indicating the active compound might be a peptide or a protein. The specificity 
against  Gram  negative  bacteria  is  interesting  because  these  bacteria  are  usually  more  resistant  to 
antimicrobial compounds due to the lipopolysaccharidic component of their cell wall.  
Sepčić et al. have screened several aqueous extracts from Mediterranean sponges and found strong 
anti-AChE activity in one species [40] that was later ascribed to alkylpyridinium polymers [41]. In the 
present study several extracts showed similar activity, however, after dilution and repeated testing only 
a  few  were  considered  worthy  of  further  investigation  (Table  3).  Inhibition  was  generally  only 
moderate,  with  one  notable  exception,  organic  extracts  from  Topsentia  ophiraphidites  showed 
considerable inhibitory activity, the most active being the butanolic extract (34 µ g) which inhibited 
almost 50% of AChE activity.  Mar. Drugs 2010, 8                       
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Compounds which inhibit or activate cell protein phosphatases/kinases, such as calyculins, are of 
special interest because of their role in cell signaling and cell cycle control [42]. Sponge extracts in 
this study showed both inhibition and activation of PP1 (Suppl. Table 1a and 1b). After dilution of 
active samples ten sponge extracts from  nine species were identified as potentially interesting for 
further research (Table 4). Several heated aqueous extracts enhanced PP1 activity by up to 2-fold. The 
only exceptions are the unheated and heated aqueous extracts from Callyspongia plicifera (#9) which 
caused 23% and 44% inhibition, respectively. Organic extracts caused PP1 inhibition only. The most 
active extracts were those from I. felix (#93), Neofibularia nolitangere (#83) and from an unidentified 
sponge (#21). From each of these species at least one organic extract totally inhibited PP1 activity. 
The concentrations necessary for total enzyme inhibition range from 54 to 790 µ g/mL. The interesting 
PP1  activation  by  several  aqueous  heated  extracts  cannot  be  explained  by  the  presence  of  innate 
protein phosphatases since those should be destroyed by heating. We cannot exclude the possibility 
that  activation  is  due  to  the  interference  between  certain  compounds  in  tested  extracts  with 
chromophores used in the PP1 inhibition assay.  
Table 1. Hemolytic activity of the most active sponge extracts. 
Sponge species  S# 
Aqueous extracts  Organic extracts
1 
Amount in the assay 
(μg/mL) 
Hemolytic activity 
Amount in the 
assay 
(μg/mL) 
Hemolytic activity 
    Unheated  Heated  Unheated
  Heated
  A  B  M  A  B  M 
Agelas clathrodes  81              32      +++ 
Ircinia felix  59          2.6  43  88  +++  +++  +++ 
Lissodendoryx 
colombiensis 
110          25      +++     
Pandaros acanthifolium  76  60.5/10.4*    +++               
Spheciospongia 
vesparium 
69  408/143*    +++               
Topsentia ophiraphidites  99  2.5/0.22*
  2.5/0
*  +++  +++  157
      +++     
1 organic extracts:
 A (acetone), B (butanol), M (methanol). 
+++, hemolytic activity (t50 between 0 and 5 min). t50 = half-time of hemolysis, e.g. the time in which 50% of 
erythrocytes are lysed. 
* protein. 
S# sample number. 
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Table 2. Antibacterial activity presented as minimal inhibitory concentration (MIC). 
Sponge species  Sample #  B. subtilis (MIC g/mL)  E. coli (MIC g/mL) 
    Aqueous extracts  Organic extracts  Aqueous 
extracts 
Organic extracts
1 
   
unheated  heated  A  B  M  unheated  heated  A  B  M 
Agelas conifera  34        2          2   
Agelas conifera  97          3           
Agelas schmidti  54      1               
Aplysina archeri  40  3050    36  8  27           
Aplysina archeri  61            50         
Callyspongia vaginalis  66        4             
Callyspongia plicifera  103                  120   
Holopsamma helwigi  5        0.4             
Hyrtios erecta  LI-10      5               
Ircinia campana  70      0. 7  7  3           
Ircinia felix  59  80  2750  0. 1  2  0. 4           
Ircinia felix  93  2.5    0. 7  1  32           
Ircinia sp.  107      0. 9  0.9  0. 1           
Ircinia cf. abseits  132      0. 3  0. 7  2           
Ircinia strobilina  56      0. 1  0.03             
Ircinia strobilina  124      17               
Lissodendoryx 
colombiensis 
51          70           
Neofibularia nolitangere  94        2             
Pseudoceratina crassa  2      0. 4               
Topsentia ophiraphidites  99      34      50  5420  3470     
Verongula gigantea  44      0.05  0. 4             
Verongula rigida  38  1650  1310  0. 6  0. 08  1.2           
Verongula rigida  105  1660        53           
Xestospongia muta  53      1.8               
Unidentified 2   
    6  6 
           
Unidentified A34  25 
    9 
             
1 Organic extracts: A (acetone), B (butanol), M (methanol). 
Table 3. Anti-acetylcholinesterase (AChE) activity of the most active sponge extracts. 
 
Sponge species 
 
S# 
Aqueous extracts  Organic extracts 
1 
Amount in the 
assay (μg/mL) 
AChE inhibition 
(%) 
Amount in the 
assay (μg/mL) 
AChE 
inhibition (%) 
    Unheated  heated  Unheated
  Heated
  A  B  M  A  B  M 
Agelas clathrodes  81  337/140*  337/0*  23  23             
Agelas conifera  97              30      28 
Topsentia ophiraphidites  99 
        31  34  217  31  46  62 
Xestospongia pacifica  LI-47  500/116
*  492/0
*  31  31    181  532    31  31 
Unidentified A33  28 
  0.78/0
* 
   
    76      23 
1 Organic extracts: A (acetone), B (butanol), M (methanol). * protein; S# sample number. Mar. Drugs 2010, 8                       
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Table 4. Modulation of protein phosphatase 1 (PP1) activity. 
Species  S#  Amount 
μg/mL 
PP1 activation /inhibition  
    aqueous  organic  aqueous  organic 
    unheated  heate
d 
A  B  M  unheated  heated  A  B  M 
Callyspongia plicifera  9  58  48        23  44       
Ircinia felix  59  283/78
*  273          x2       
Ircinia felix  93  244/70
*  200  176  275  790    x1.5  33  67  100 
Ircinia strobilina  56  192/55
*  177          x1.4       
Ircinia cf. abseits  13
2 
346/41
*  227          x1.5       
Neofibularia nolitangere  83      28  54  167      67  100  100 
Spheciospongia 
vesparium 
69          78          50 
Verongula gigantea  44  388/138
*  319          x2       
Verongula rigida  38  164/54
*  130          x2       
Unidentified 1  21      73  117  673      100  100  100 
Organic extracts:
 A (acetone), B (butanol), M (methanol). 
Activation is indicated in italics, and denotes a factor by which the PP1 activity is enhanced. 
Inhibition is indicated in normal text, and denotes the % of inhibition.  
*protein. 
S# sample number. 
3. Experimental Section 
3.1. Sponge collection 
Sixty-six sponge specimens were studied, represented by 43 sponge species (Table 1a and 1b). 
Thirty-five were collected by SCUBA by Dr. Daniel Schaft at depths from 5 to 45 m in the reefs of 
Curaç ao (Netherlands Antilles) at several locations: the entrance of Picadera Bay, coastline of Charo 
and  Boca  Sami.  The  specimens  were  taxonomically  determined  to  species  level,  seven  remained 
unidentified.  The  other  eight  species  were  collected  from  Lizard  Island  (Great  Barrier  Reef, 
Queensland, Australia), and identified to at least genus level.  
3.2. Sample preparation 
All sponge samples were lyophilized and dried weight was determined. The total material was 
divided into two parts; one part for aqueous extraction, the other subjected to extraction with organic 
solvents. The total mass of freeze-dried sponge samples was within the range from 0.35 g to 36.8 g.  
3.3. Aqueous extraction  
One half of total lyophilized mass of each sponge specimen was homogenized, dissolved in 10 mL 
of  deionized  water  and  extracted  for  12  hours  with  constant  shaking  (400  rpm  at  
4 ° C) followed by centrifugation (15,000 rpm at 4 ° C). Supernatants were removed and divided into Mar. Drugs 2010, 8                       
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two parts. The first part was unheated and was stored in aliquots of 1 mL at -20 ° C. The second portion 
supernatants was boiled for 15 min at 100 ° C, cooled and centrifuged for 15 min at 13,000 rpm. The 
resulting » heated«  supernatants were stored in 1 mL aliquots at -20 ° C. The dry weight of each sample 
was determined using 500 µ L of each sample which was placed for 30 min into an oven and dried at 
120 °C . The dry weight was expressed in mg/mL. Stock concentrations of unheated aqueous extracts 
were from 5.85 to 95.40 mg/mL (proteins from 0.46 to 44.18 mg/mL), those of heated fractions from 
4.80 to 86.72 mg/mL. 
3.4. Protein determination 
The  protein  content  was  determined  only  in  unheated  samples  and  measured  by  BCA  protein 
reagent  according  to  the  manufacturers  manual  (Pierce,  USA).  Different  concentrations  of  bovine 
serum albumin (Sigma, USA) were used as a standard. Prior to the addition of the reagent, samples 
were diluted 1:20 (v/v) with deionized water. The colour formation was determined at 562 nm using 
microtiter plate reader (Dynex Technologies, USA) after 30 min of incubation. 
3.5. Extraction with organic solvents 
One half of each total lyophilized sponge body mass was macerated and divided into three parts 
which were placed into three labeled tubes (A, acetone; B, butanol; M, methanol, all solvents were 
from Merck, Germany). To the each tube, the solvent was added in a way that its volume was about  
1  cm  above  the  sample.  Tubes  were  sealed  with  metal  stoppers  and  parafilm  and  were  shaken 
overnight at 37 ° C. The extracts were filtered and the remaining material was subjected to repeated 
extraction for 3 hours at 37 ° C with constant shaking. Both filtrates were combined and put into 
Erlenmayer flasks. The solvents were evaporated, and each of the resulting supernatants resuspended 
in 2 ml of 96% ethanol (Merck, Germany). Dry weight of each sample was determined by drying an 
aliquot of a sample in a preweighed round bottom flask by evaporation under vacuum at 45 ° C. The 
dry  weight  was  expressed  in  mg/mL.  Stock  concentrations  were  in  the  following  ranges:  0.48  to  
39.75 mg/mL for acetone, 1.08 to 72.8 mg/mL for butanol, and 16.84 to 239.11 mg/mL for methanol 
extracts, respectively. 
3.6. Hemolytic activity assay 
Fresh bovine erythrocytes were used for hemolytic tests. Red blood cells were washed three times 
in physiological saline prior to use. Finally, they were diluted in a buffer containing 0.13 M NaCl in 
0.02  M  TRIS-HCl,  pH  7.4.  The  erythrocyte  suspension  had  an  initial  absorption  value  of  
1.0 ±  0.01 AU at 650 nm. Hemolytic activity was assayed using a microplate UV/VIS absorbtion 
reader (Dynex, USA). To each well 100 µ L of buffer was added followed by 20 µ L ethanol-dissolved 
acetone, buthanol or methanol extracts, respectively. Finally, 100 µL of erythrocyte suspension was 
added to initiate the assay. Time course of hemolysis was monitored until the absorption dropped to 
the half of its initial value (approx. 0.250 AU) and expressed as a half-time of hemolysis (t50). All 
measurements were done at 25 °C . Blind experiments were conducted, using 20 µ L water or absolute 
ethanol as controls. Samples showing the highest hemolytic activity were further diluted (1:2, 1:10 and Mar. Drugs 2010, 8                       
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1:20 for organic extracts and 1:10, 1:100 and 1:1000 for aqueous extracts, respectively). Assays with 
diluted samples were repeated accordingly.  
3.7. Antibacterial activity assay 
Antibacterial  activity was tested by means of a standard agar plate diffusion assay. The Gram 
positive Bacillus subtilis and the Gram negative Escherichia coli bacterial strains (obtained from the 
microbial  collection  at  the Chair  for Microbiology, Biotechnical Faculty,  University of Ljubljana, 
Slovenia) were used. Precultured bacteria (grown in Luria broth media, Sigma, USA) were used for 
the inoculation of Luria broth agar plates in a final concentration of 5 ×  10
5 cells/L. Four holes (1 cm 
in diameter) were made into each agar plate and filled with 100 μL of unheated or heated samples in 
the case of aqueous extracts. In the case of organic extracts to the each hole 100 µ L of ethanol-
dissolved acetone, butanol or methanol samples were added. The fourth hole was used for the control 
and was filled with ethanol. The inhibition zone for each sample was determined after the overnight 
incubation of plates at 37° C. Samples showing the highest inhibition of bacterial growth were further 
diluted with deionized water or ethanol (1:10, 1: 100 and 1:1000), tests were repeated and minimal 
inhibitory concentrations were calculated (MIC = the concentration in μg/mL that inhibits the growth 
of tested microorganism 1 mm from the rim of the hole).  
3.8. Hemagglutination assay 
Samples obtained by aqueous extraction were tested for hemagglutinating activity. Fresh bovine 
erythrocytes were washed twice in buffer as described above (see hemolytic activity assay). Two per 
cent final erythrocyte suspension was prepared using the same buffer. The erythrocyte suspension  
(100 µ L) was added to each well of a 96 round-well microtitre plate, followed by 25 µ L of samples. 
Hemagglutination was visually inspected after 45 min of incubation at room temperature.  
3.9. Acetylcholinesterase inhibition assay 
The  acetylcholinesterase  assay  was  performed  according  to  the  method  of  Ellman  et  al.  [28]. 
Briefly, AChE from electric eel (Sigma, USA), was dissolved in 100 mM phosphate buffer (pH 7.3) to 
achieve  500 EU/mL. Prior to  the test,  enzyme  was 100 fold diluted  in the same buffer. To each 
microtiter  plate  well  140  µ L  of  the  Ellman  reagent  (5,5-dithiobis-2-nitrobenzoic  acid)  in  25  mM 
phosphate buffer (pH 7.0), 10 µ L of acetylcholine (ACh) in 1 mM final concentration, 20 ul of sponge 
sample (aqueous or organic), and finally 50 µ L of AChE was added to start the reaction. Deionized  
(20 µ L) water or ethanol (20 µ L) was used as controls. The time course of the enzymatic reaction was 
monitored for 12 min at 412 nm and 25 ° C. Samples that showed significant AChE inhibitory activity 
were  further  diluted  (1:10  and  1:100)  and  tested  accordingly.  UV/VIS  microplate  reader  (Dynex, 
USA) was used in all assays.  Mar. Drugs 2010, 8                       
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3.10. Protein phosphatase 1 inhibition/activation assay 
The effects of sponge samples on PP1 activity were monitored colorimetrically according to Tubaro 
et al. [29] using a microplate reader (Dynex, USA). Rabbit recombinant α-isoform PP1 expressed in E. 
coli (Sigma, USA) was the enzyme used. To each well of the microtiter plate 150 µ L of buffer (40 mM 
TRIS/HCl, 34 mM MgCl2 .6H2O, 4 mM EDTA and 4 mM DL-DTT, pH 8.4), 50 µ L of the substrate 
(141 mM p-nitrophenil phosphate) and 2 µ L of sponge samples (2 µ L of deionized water or ethanol in 
the controls) was added. The reaction was started by the addition of 50 µ L of buffer-dissolved PP1 
(0.25 U/mL). Samples that showed activity were further diluted (1:10 and 1:100 v/v). All reactions 
were monitored for 12 min at 25 °C  for the colour development at 405 nm. 
4. Conclusions 
We conclude that almost all sponge extracts tested in this study showed at least one activity, but 
only few represent a promising source for further research into their active components. Most of these 
components  are  probably  smaller  organic  compounds  whose  activity  is  not  destroyed  by  heating. 
However, some active components might be larger, most probably proteins, whose activity is lost upon 
heating as a result of denaturation. The most interesting species in terms of different activities were 
Ircinia felix, Topsentia ophiraphidites and Pandaros acanthifolium. Bioassay guided isolation and 
characterization of the active components from these species may yield useful candidates in the search 
for new pharmaceutical leads. 
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Supplement Table 1a. List of species from Curaç ao (Netherland Antilles). 
Species  S #  Hemolytic 
activity 
Antibacterial activity 
(inhibition zone mm) 
Hem-
agglutination 
AChE inhibition 
 
PP1 activation/inhibition 
      B. subtilis   E. coli    aqueous  Organic  aqueous  organic 
    aq  aqh  A  B  M  aq  aqh  A  B  M 
Agelas clathrodes  81  +++
A,B,M  2
aq, 3
aqh 
2
A, 2
B, 5
M  
        +++  +  +++          i 
Agelas conifera  34    .5
A, 8
B, 10
M   .5
A, 8
B, 10
M     +++  +++    +++  +++           
Agelas conifera  97    4
A, 2
B, 9
M   1.5
A,1
B, 6
M     +++  +++  +    +++    i  i  i   
Agelas dispar  58                  +++          iii 
Agelas dispar  88    2
A, 2
B, 3
M         +  +  ++  ++    i  i  ii  i 
Agelas schmidti  54    9
A, 9
B, 9
M   0.5
B                       
Aplysina archeri  40    3.5
aq 
3
A, 5
B, 4
M 
 
2
A, 1
B, 1
M 
  +
aq  +++  +++  +  +  ++      iii  iii  iii 
Aplysina archeri  61  ++
A,B  6
aq 
3
A, 3
B, 6
M  
2
aq 
1
A, 1
B, 3
M  
+
aqh  +        +++    ii       
Alpysina cauliformis  84  ++
A,B, +
M  2
aq 
2
A,2
B,3
M 
 
            ++  ii  ii       
Aplysina fistularis  57  ++
A,B  2
A, 2
B, 2
M   1
A, 1
B, .5
M                 ii       
Aplysina fulva  10  +++
A, ++
B,M  6
aq  
3
A, 3
B, 10
M 
 
4
aq 
2
A, 1
B, 6
M  
  +  +      +++  ii  ii       
Aplysina lacunosa  41  ++
A,B, +
M  2
A, 2
B, 2
M         +      +           
Aplysina lacunosa  112    3
A, 3
B, 2
M     +
aq  +++  +++  +  +  +++      ii  ii   
Callyspongia plicifera  9    2
A, 1
B, 2
M               +  i  i  ii  ii  i 
Callyspongia plicifera  67    3
A, 2
B, 2
M               +    ii  i  ii  i 
Callyspongia plicifera  103    3
A, 2
B, 1
M   1
A, 2
B, 1
M                   i  ii  iii 
Callyspongia plicifera  127    2
A, 2
B, 1
M                   a       
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Suppl. Table 1a. Cont. 
Callyspongia vaginalis  15    1
A, 1
B   1
B                  ii  i  iii 
Callyspongia vaginalis  48    2
A, 2
B, 2
M   1
B, 2
M             +    ii  ii  iii  iii 
Callyspongia vaginalis  66    3
A, 4
B, 1
M     +
aq      +  +  ++    i  i  i  i 
Geodia neptuni  87  +
A,M  3
A, 2
B, 2
M           ++        ii       
Holopsamma helwigi  5    3
A, 5
B, 2
M     +
aq          +      ii  ii  ii 
Holopsamma helwigi  122         +
aq                     
Iotrochota birotulata  77    4
A, 4
B, 4
M   1
A, 4
B, 4
M   +
aq, +
aqh  ++  +  +++  ++  +++      i  iii   
Ircinia campana  70  +
A,B  7
A, 5
B, 6
M           +  +  ++    a  ii  i  i 
Ircinia felix  59  +++
A,B,M  5
aq, 5.3
aqh 
9
A,10
B, 9
M  
      +  ++  ++  ++    a  i  ii  ii 
Ircinia felix  93  +
A,M, ++
B   3
aq, 2.1
aqh 
13
A,12
B, 9
M  
    ++  +  +  ++  ++    a  i  ii  iii 
Ircinia felix  129  +++
A  5
A, 2
B, 5
M                     ii  i  ii 
Ircinia strobilina  56  ++
A, +
B  0.5
aq 
10
A, 3
B, 4
M  
        +    +    a  i  i  i 
Ircinia strobilina  124  +++
A,M, ++
B  9
A, 2
B, 10
M               +  ii        i 
Lissodendoryx colombiensis  51  +
aq 
++
A, +
B 
4
aq 
2
A, 2
B, 7
M 
 
2
aq 
2
M 
+
aq            ii  ii  i  i   
Lissodendoryx colombiensis  110  +++
A  10
A, 3
B, 4
M   1
A        ++  +  +++      i    ii 
Myrmekioderma styx  86  ++
A, +
B  4
A, 4
B, 3
M   .5
A, .5
B, .5
M   +
aq, +
aqh      ++  ++      a       
Neofibularia nolitangere  49  ++
A, +
B  2
A, 2
B, 2
M   .5
A                       
Neofibularia nolitangere  83    3
A, 3
B, 2
M   1
M          +  +      ii  iii  iii 
Neofibularia nolitangere  94    4
A, 4
B, 3
M   2
A, 1
M     ++            i  i  i  i 
Pandaros acanthifolium  14    3
A, 2
B, 2
M   1
A, 1
B, 1
M                     i  ii 
Pandaros acanthifolium  76  +++
aq  3
A, 2
B, 5
M   .5
A, .5
B, .5
M         +  +  +  iii  iii  ii  i  i 
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Pseudoceratina crassa  2     3
aq 
7
A, 3
B, 7
M  
1
B  +
aq  +  +  +  +  ++        i  ii 
Pseudoceratina crassa  104   +++
A, ++
M  3
A, 2
B, 2
M     +
aq  +    ++      ii  ii  i  i   
Scopalina ruetzleri  78    2
A, 1
B, 2
M       +  +            i    i 
Spheciospongia vesparium  45     2
A, 2
B, 2
M   1
A,1
M      +      ++      i  i   
Spheciospongia vesparium  69   +++
aq  
++
B, +++
M 
2
A, 2
M       +  +      ++  iii  iii    i  iii 
Topsentia ophiraphidites  99  +++
aq,  +++
aqh, 
+++
A, ++
M 
7
aq, 8
aqh  
7
A, 7
B, 7
M 
 
3
aqh 
4
A, 4
B, 4
M  
  +++  ++  +++  +++  +++  ii  ii  ii  i   
Tridideum misolidum  79    3
A, 2
B, 2
M   1
A, 2
B                   ii  ii  ii 
Verongula gigantea  44    5
A, 4
B, 4
M   1
A, 1
B, 1
M     +++  ++  +  +  ++    a  i  i  i 
Verongula rigida  38    5
aq, 5.2
aqh 
6
A, 6
B, 6
M  
1
aqh 
1
A, 1
B  
      +  ++  ++    a  i  i  i 
Verongula rigida  105  +
A  5
aq  
7
A, 3
B, 10
M  
1
A, 2
M     +    +    +           
Xestospongia muta  53  +++
B,M  10
A, 7
B, 6
M                         i 
Xestospongia muta  95    4
A, 6
B, 5
M             +  +    i       
Unidentified A21  114  +
aq  2
A, 1
B, 5
M   2
M                       
Unidentified A33  28  ++
A,B,M  3
aq, 2
aqh    +
aq  +++  +++      +++    ii    iii  iii 
Unidentified A34  25  ++
A,B  5
A, 4
B, 4
M                          
Unidentified 1  21    2
A, 2
B, 3
M   1
A, 1
B    ++  ++  +  +  +++    ii  iii  iii  iii 
Unidentified 2  32  +
B  4
A, 4
B, 3
M   1
A, 1
B, 1
M     +++  +++  +  ++  ++      ii  ii  ii 
Unidentified 3  96    2
A, 3
B, 2
M             +  ++      i  i  ii 
Unidentified 4  117  ++
aq  3
A, 3
B, 2
M     +
aq  +  +  +  +  +    a  i  i  i 
aq aqueous unheated, 
aqh aqueous heated  
Organic extracts:
 A (acetone), B (butanol), M (methanol)
  
Hemolytic activity: +, moderate activity (t50 between 10 and 15 min); ++, strong activity (t50 between 5 and 10 min); +++, very strong activity (t50 between 0 and 5 min). 
t50 = half-time of hemolysis, e.g. the time in which 50% of erythrocytes are lysed. 
AChE inhibition: +, moderate inhibition (0–33%); ++, strong inhibition (34–66%); +++, very strong inhibition (67–100%). 
PP1 activation/inhibition: a, activation (up to 100%); i, moderate inhibition (0–33%); ii, strong inhibition (34–66%); iii, very strong inhibition (67–100%). 
S# sample number. Mar. Drugs 2010, 8                       
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Supplement Table 1b. List of species from Lizard island (Great Barrier Reef, Queensland, Australia). 
Species  S.#  Hemolytic 
activity 
Antibacterial activity 
(inhibition zone mm) 
Hem- 
aglutination 
AChE inhibition 
 
PP1 activation/inhibition 
      B. subtilis   E. coli    aqueous  Organic  aqueous  organic 
   
        aq  aqh  A  B  M  aq  aqh  A  B  M 
Hyrtios erecta  LI-10  +
A  4
A, 4
B, 4
M                         iii 
Ircinia sp.  LI-39    2
A, 2
B, 2
M       ++                   
Ircinia sp.  107  ++
A,B, +
M  9
A,10
B, 9
M           +  +  +    i  ii  ii  i 
Ircinia cf. Abseits  132   +
A, ++
B  8
A, 8
B, 6
M           +  +  +    a  i  ii  i 
Pericharax heteroraphis  LI-35  +++
A,
 ++
B, +
M  2
A, 2
B, 2
M                   a      i 
Phakellia stipitata   LI-5    4
A, 3
B, 4
M                         ii 
Spongia sp.  LI-43  +
A  2
A, 2
B, 2
M       +                  i 
Thorectandra sp.  LI-27  +
A, +
B  3
A, 2
B, 3
M     +
aq  +    +++  ++  +++      i    i 
Xestospongia pacifica  LI-47 
  3
A, 3
B, 3
M   2
A, 1
M     +++  +++  ++  +++  +++  iii  i  iii  iii  iii 
aq aqueous unheated, 
aqh aqueous heated.  
Organic extracts:
 A (acetone), B (butanol), M (methanol).
  
Hemolytic activity: +, moderate activity (t50 between 10 and 15 min); ++, strong activity (t50 between 5 and 10 min); +++, very strong activity (t50 between 0 and 5 min). 
t50 = half-time of hemolysis, e.g. the time in which 50% of erythrocytes are lysed. 
AChE inhibition: +, moderate inhibition (0–33%); ++, strong inhibition (34–66%); +++, very strong inhibition (67–100%). 
PP1 activation/inhibition: a, activation (up to 100%); i, moderate inhibition (0–33%); ii, strong inhibition (34–66%); iii, very strong inhibition (67–100%). 
S# sample number. 
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